Vijay Kondreddy

About

I am Vijay Kondreddy aka Vijay Kumar Reddy, Kondreddy, completed by BS degree in 2008 and MS degree in 2010 from Sri Venkateshwara University , Tirupati, India. I did my doctoral studies on the topic " Studies on lipids as modulators of mucosal immunity and Inflammation" in Dec 2016. Subsequently, I have joined as a post-doctoral research associate with Dr. Rao LVM at The University of Texas , Texas, USA. I have received post-doctoral training in cell-signaling, coagulation biology, vascular biology and Inflammation. From July 2022-2024, I worked as a Scientist at CSIR-IICT, Hyderabad, India. Currently, I am working as a Associate Professor at Central University of Punjab, Bathinda, India. My future research interests are to understand how cell-signaling adaptor protein called Gab2 relay cell-signaling of proinflammatory receptors and contribute to the inflammation , endothelial dysfunction, and development of cardiovascular diseases. These studies enable to identify Gab2-signaling blockers as novel therapeutics to treat the pulmonary and cardiovascular diseases.

Employment

• Central University of Punjab Associate Professor
  2026 - 2037
• Central University of Punjab Assistant Professor / Ramanujan Fellow
  2024 - 2026
• Indian Institute of Chemical Technology Scientist D/ Ramanujan Fellow
  2022 - 2024
• The University of Texas at Dallas Post-doctoral Research Associate
  2016 - 2022
• University of Mysore Senior Research Fellow
  2013 - 2016
• University of Mysore Junior Research Fellow
  2011 - 2013

Education

• University of Mysore Doctor of Philosopshy
  2011 - 2016
• Sri Venkateswara University Masters in Science
  2008 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Interception of Regulatory RNAs on TGF-β Signaling in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Systematic Review.
  Current allergy and asthma reports 2026 0 citations DOI: 10.1007/s11882-026-01276-3
  +Save
• Liver specific-inhibition of LPCAT3 ameliorates metabolic dysfunction-associated steatotic liver disease
  Journal of Molecular Medicine 2026 0 citations DOI: 10.1007/s00109-026-02648-y
  +Save
• LPCAT3-dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis.
  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2025 7 citations DOI: 10.1007/s00011-025-02132-2
  +Save
• IN-VIVO AND IN-VITRO ANTI-INFLAMMATORY AND ANTI-ARTHRITIC ACTIVITY OF SYNTHETIC CIS-9 AND CIS-10 CETYL MYRISTOLEATE (CMO) ISOMERS IN MICE
  International Journal of Advanced Research 2025 0 citations DOI: 10.21474/ijar01/20594
  +Save
• LPCAT3-ABCA1 axis regulates the dose-sparing effects of steroid drugs in osteoarthritis in mice
  International Journal of Biological Macromolecules 2025 2 citations DOI: 10.1016/j.ijbiomac.2025.148140
  +Save
• Design, Synthesis and Biological Evaluation of Novel Capsaicin Analogues Containing Heterocyclic Fatty Acids
  Chemistryselect 2024 4 citations DOI: 10.1002/slct.202402179
  +Save
• Genomic analysis in the colon tissues of omega-3 fatty acid-treated rats identifies novel gene signatures implicated in ulcerative colitis
  International Journal of Biological Macromolecules 2024 10 citations DOI: 10.1016/j.ijbiomac.2023.128867
  +Save
• Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis
  Cell Communication and Signaling 2024 15 citations DOI: 10.1186/s12964-024-01547-4
  +Save
• Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease
  International Journal of Biological Macromolecules 2024 8 citations DOI: 10.1016/j.ijbiomac.2024.137235
  +Save
• The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis.
  Blood 2022 45 citations DOI: 10.1182/blood.2022016424
  +Save